Paper Details 
Original Abstract of the Article :
BACKGROUND: Controlled trials of cilostazol for claudication demonstrate improvements in walking distance and quality of life. Without the structure of a study environment, it is not certain that cilostazol has similar efficacy. METHOD: Retrospective review of patients prescribed cilostazol for cla...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/1538574413518121

データ提供:米国国立医学図書館(NLM)

Cilostazol for Intermittent Claudication

This study investigates the effectiveness of cilostazol, a medication used to treat intermittent claudication, a condition characterized by leg pain during physical activity. The researchers retrospectively reviewed the records of patients prescribed cilostazol for claudication and found that a significant number of patients reported an improvement in their symptoms. This finding suggests that cilostazol could be a valuable treatment option for intermittent claudication, despite the lack of a structured treatment program.

Cilostazol - A Potential Solution for Intermittent Claudication

The study's findings provide evidence for the efficacy of cilostazol in managing intermittent claudication, a condition that can significantly impact a patient's quality of life. The researchers found that a significant proportion of patients reported symptom improvement while taking cilostazol, highlighting its potential as a valuable treatment option for this condition.

Keeping Your Legs Moving

Imagine a camel trekking across a vast desert landscape, its strong legs carrying it through the challenging terrain. Just as the camel relies on its legs for mobility, individuals with intermittent claudication need effective treatments to maintain their mobility and independence. This study suggests that cilostazol could be a valuable tool in managing this condition, allowing individuals to continue pursuing an active lifestyle.

Dr.Camel's Conclusion

This study provides evidence for the effectiveness of cilostazol in improving symptoms associated with intermittent claudication. The researchers found that a significant number of patients reported symptom improvement while taking cilostazol, despite the lack of a structured treatment program. This finding suggests that cilostazol could be a valuable treatment option for this condition, providing patients with a better quality of life.
Date :
  1. Date Completed 2014-11-03
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

24399131

DOI: Digital Object Identifier

10.1177/1538574413518121

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.